Global Postmenopausal Vaginal Atrophy Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 12-Sep-2018
No. of pages: 122

Postmenopausal vaginal atrophy (PVA) refers to reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased elasticity of vaginal tissues. Various other factors that lead to decrease in estrogen levels include perimenopause during breast feeding, surgical menopause, pelvic radiation therapy, and chemotherapy.

Scope of the Report:

This report focuses on the Postmenopausal Vaginal Atrophy Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Postmenopausal Vaginal Atrophy Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Actavis plc

- Bionovo, Inc.

- Endoceutics, Inc.

- Novo Nordisk A/S

- Pfizer Inc.

- Teva Pharmaceuticals Ltd.

- Therapeutics MD, Inc.

- Shionogi & Company

- Allergan plc

- Shionogi & Co. Ltd.

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Premarin

- Vagifem

- Estrace

- Estring

- Femring

Market Segment by Applications, can be divided into

- Vaginal Gels

- Creams

- Tablets

- Rings

- Patches

There are 15 Chapters to deeply display the global Postmenopausal Vaginal Atrophy Drugs market.

Chapter 1, to describe Postmenopausal Vaginal Atrophy Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Postmenopausal Vaginal Atrophy Drugs, with sales, revenue, and price of Postmenopausal Vaginal Atrophy Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Postmenopausal Vaginal Atrophy Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Postmenopausal Vaginal Atrophy Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Postmenopausal Vaginal Atrophy Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Postmenopausal Vaginal Atrophy Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Postmenopausal Vaginal Atrophy Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Premarin
1.2.2 Vagifem
1.2.3 Estrace
1.2.4 Estring
1.2.5 Femring
1.3 Market Analysis by Applications
1.3.1 Vaginal Gels
1.3.2 Creams
1.3.3 Tablets
1.3.4 Rings
1.3.5 Patches
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Actavis plc
2.1.1 Business Overview
2.1.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bionovo, Inc.
2.2.1 Business Overview
2.2.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Endoceutics, Inc.
2.3.1 Business Overview
2.3.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novo Nordisk A/S
2.4.1 Business Overview
2.4.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer Inc.
2.5.1 Business Overview
2.5.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceuticals Ltd.
2.6.1 Business Overview
2.6.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Therapeutics MD, Inc.
2.7.1 Business Overview
2.7.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Shionogi & Company
2.8.1 Business Overview
2.8.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Allergan plc
2.9.1 Business Overview
2.9.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shionogi & Co. Ltd.
2.10.1 Business Overview
2.10.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Postmenopausal Vaginal Atrophy Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Postmenopausal Vaginal Atrophy Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Postmenopausal Vaginal Atrophy Drugs Market Analysis by Regions
4.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
4.5 South America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
5 North America Postmenopausal Vaginal Atrophy Drugs by Countries
5.1 North America Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
6 Europe Postmenopausal Vaginal Atrophy Drugs by Countries
6.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
6.3 UK Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
6.4 France Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs by Countries
7.1 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
7.5 India Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
8 South America Postmenopausal Vaginal Atrophy Drugs by Countries
8.1 South America Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs by Countries
9.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
10 Global Postmenopausal Vaginal Atrophy Drugs Market Segment by Type
10.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Type (2013-2018)
10.2 Premarin Sales Growth and Price
10.2.1 Global Premarin Sales Growth (2013-2018)
10.2.2 Global Premarin Price (2013-2018)
10.3 Vagifem Sales Growth and Price
10.3.1 Global Vagifem Sales Growth (2013-2018)
10.3.2 Global Vagifem Price (2013-2018)
10.4 Estrace Sales Growth and Price
10.4.1 Global Estrace Sales Growth (2013-2018)
10.4.2 Global Estrace Price (2013-2018)
10.5 Estring Sales Growth and Price
10.5.1 Global Estring Sales Growth (2013-2018)
10.5.2 Global Estring Price (2013-2018)
10.6 Femring Sales Growth and Price
10.6.1 Global Femring Sales Growth (2013-2018)
10.6.2 Global Femring Price (2013-2018)
11 Global Postmenopausal Vaginal Atrophy Drugs Market Segment by Application
11.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2013-2018)
11.2 Vaginal Gels Sales Growth (2013-2018)
11.3 Creams Sales Growth (2013-2018)
11.4 Tablets Sales Growth (2013-2018)
11.5 Rings Sales Growth (2013-2018)
11.6 Patches Sales Growth (2013-2018)
12 Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
12.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
12.2.2 Europe Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
12.2.4 South America Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
12.3 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Type (2018-2023)
12.4 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Postmenopausal Vaginal Atrophy Drugs Picture
Table Product Specifications of Postmenopausal Vaginal Atrophy Drugs
Figure Global Sales Market Share of Postmenopausal Vaginal Atrophy Drugs by Types in 2017
Table Postmenopausal Vaginal Atrophy Drugs Types for Major Manufacturers
Figure Premarin Picture
Figure Vagifem Picture
Figure Estrace Picture
Figure Estring Picture
Figure Femring Picture
Figure Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Applications in 2017
Figure Vaginal Gels Picture
Figure Creams Picture
Figure Tablets Picture
Figure Rings Picture
Figure Patches Picture
Figure United States Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Actavis plc Basic Information, Manufacturing Base and Competitors
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bionovo, Inc. Basic Information, Manufacturing Base and Competitors
Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Endoceutics, Inc. Basic Information, Manufacturing Base and Competitors
Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Therapeutics MD, Inc. Basic Information, Manufacturing Base and Competitors
Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi & Company Basic Information, Manufacturing Base and Competitors
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan plc Basic Information, Manufacturing Base and Competitors
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi & Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Type and Applications
Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Manufacturer (2016-2017)
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Manufacturer in 2016
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Manufacturer in 2017
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Manufacturer (2016-2017)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Postmenopausal Vaginal Atrophy Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Postmenopausal Vaginal Atrophy Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Regions (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Regions (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Regions (2013-2018)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions in 2013
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions in 2017
Figure North America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure South America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)
Table North America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)
Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2013
Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017
Table North America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)
Table North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2013
Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017
Figure United States Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Canada Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)
Table Europe Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2016
Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017
Figure Germany Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure UK Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure France Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Russia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Italy Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries 2017
Figure China Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Korea Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure India Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure South America Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)
Table South America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)
Table South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)
Figure South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017
Table South America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)
Table South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017
Figure Brazil Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure UAE Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Type (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Type (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Type (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Type (2013-2018)
Figure Global Premarin Sales Growth (2013-2018)
Figure Global Premarin Price (2013-2018)
Figure Global Vagifem Sales Growth (2013-2018)
Figure Global Vagifem Price (2013-2018)
Figure Global Estrace Sales Growth (2013-2018)
Figure Global Estrace Price (2013-2018)
Figure Global Estring Sales Growth (2013-2018)
Figure Global Estring Price (2013-2018)
Figure Global Femring Sales Growth (2013-2018)
Figure Global Femring Price (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Application (2013-2018)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Application (2013-2018)
Figure Global Creams Sales Growth (2013-2018)
Figure Global Tablets Sales Growth (2013-2018)
Figure Global Rings Sales Growth (2013-2018)
Figure Global Patches Sales Growth (2013-2018)
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Regions (2018-2023)
Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
Figure Europe Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
Figure South America Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Type (2018-2023)
Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Type (2018-2023)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Application (2018-2023)
Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Eucalyptus Oil Market Growth 2019-2024
    Published: 22-Feb-2019        Price: US 3660 Onwards        Pages: 161
    Eucalyptus oil is the generic name for distilled oil from the leaf of Eucalyptus, a genus of the plant family Myrtaceae native to Australia and cultivated worldwide. Eucalyptus oil is one of the most common and widely used essential oils and has a good health care effect. It is colorless or slightly yellow liquid. It is characterized by a cool spiky, leafy aroma and a somewhat camphor-like odor, almost insoluble in water, soluble in ethanol, anhydrous ethanol, oil and fat. The flash point......
  • Global Compounding Pharmacy Market Growth (Status and Outlook) 2019-2024
    Published: 22-Feb-2019        Price: US 3660 Onwards        Pages: 134
    The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients. Comp......
  • Global Flu Vaccine (Influenza Vaccine) Market Growth 2019-2024
    Published: 22-Feb-2019        Price: US 3660 Onwards        Pages: 132
    Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. The classification of Flu Vaccine includes Who......
  • Global Medicinal Mushroom Extracts Market Growth 2019-2024
    Published: 22-Feb-2019        Price: US 3660 Onwards        Pages: 164
    Medicinal mushrooms have long been recognized for their health benefits in Eastern medicine; traditional medicine has used mushrooms for thousands of years. Studies have found that these medicinal mushrooms contain a variety of components that act as antioxidants, support immune function, and even promote cellular health and function. The classification of Medicinal Mushroom Extracts includes powder and liquid, and the proportion of powder in 2016 is about 80%. Medicinal Mushroom E......
  • Global Plasminogen Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Feb-2019        Price: US 3480 Onwards        Pages: 120
    Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). The complete amino acid sequence contains 790 amino acids. Native plasminogen (glu-plasminogen) has a N-terminal glutamic acid group. Partial plasma proteolysis gives rise to a molecule with N-terminal lysine (lysplasminogen).......
  • Global Pharma & Cosmetics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Feb-2019        Price: US 3480 Onwards        Pages: 139
    Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases. Scope of the Report: Pharmaceutical (OTC) occupies an important share in the pharmaceutical industry. Pharmaceuticals (OTC) can be classified into ointment......
  • Global Platelet Rich Plasma (PRP) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 22-Feb-2019        Price: US 3480 Onwards        Pages: 123
    Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue. Scope of the Rep......
  • Global Real Time Polymerase Chain Reaction Systems Industry Market Research 2019
    Published: 22-Feb-2019        Price: US 2600 Onwards        Pages: 156
    In this report, we analyze the Real Time Polymerase Chain Reaction Systems industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 201......
  • Global Smart Pills Technology Industry Market Research 2019
    Published: 22-Feb-2019        Price: US 2600 Onwards        Pages: 159
    In this report, we analyze the Smart Pills Technology industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs